Live Terminal
Telegram
#ICICIBANK#SBIN

Sun Pharma to raise Rs 10,000 crore to part-finance Organon deal

Share on WhatsApp Telegram
⚡ Instant Key Takeaways (TL;DR)
🎯
Core Development: Sun Pharma to raise Rs 10,000 crore to part-finance Organon deal
📊
Market & Financial Impact: Sun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance bridge loans taken for the Organon acquisition valued at $11.75 billion. The first tranche will amount to ₹7,000 crore with a coupon rate of 8.20%. Institutional investors are expected to participate, including notable companies like SBI Pension Fund and ICICI Prudential Mutual Fund.
💡
Actionable Insight: Monitor price volume action at market open; check key technical support/resistance levels.

One tranche of ₹7,000 crore carries a coupon of 8.20%, while a ₹3,000 crore tranche carries a coupon of 8.05% and includes a put option in 2028.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

One company, 2 words. Bond yield and CDS: Will they decide the fate of global markets?

Business of Odd Things: Inside an industry that farms fish that nobody is meant to eat

📰
Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.
Read Original Full Coverage on Economic Times ↗
⚡
Get Breaking Stock Alerts & Q-Results on Telegram
Real-time 1200x675 image cards and financial filings delivered instantly.
Join @Zerolive_news ↗
Link copied to clipboard! ✅